pali-2108
pali-2108: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PALISADE BIO, INC. (PALI) | Phase 1 |
Clinical Trials (1)
A Phase 1, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of PALI-2108 in Healthy Volunteers, With an Open-Label Study of a Patient Cohort With Ulcerative Colitis and a Phase 1b, Open-Label, Cohort in Patients With Fibrostenosing Crohn's Disease
Frequently asked questions
Who is developing pali-2108?
pali-2108 is being developed by PALISADE BIO, INC..
How many clinical trials involve pali-2108?
BioSniper tracks 1 clinical trial involving pali-2108.
Get deeper analysis on pali-2108
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis